Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monish Jain

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|December 4, 2003
1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activationMonish Jain, Chul-Hoon Kwon
Biomedical Chromatography : BMC|April 10, 2024
Highly sensitive liquid chromatography-mass spectrometry method for the quantitative analysis of mometasone furoate in human plasma: Method validation and application to clinical pharmacokinetic studiesOlivier Heudi, Monish Jain, Serge Winter
Journal of Medicinal Chemistry|July 9, 2004
Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell linesMonish Jain, Junying Fan, Nesrine Z Baturay, et al.
Translational Vision Science & Technology|November 17, 2022
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy ParticipantsKalliopi Stasi, Qusai Alshare, Monish Jain, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 23, 2021
Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler<sup>®</sup> Device in Patients with AsthmaChristian Bartels, Monish Jain, Jing Yu, et al.
Drug Research|March 8, 2021
Xinting Wang, Christian Bartels, Swarupa Kulkarni, et al.
Frontiers in Pharmacology|August 15, 2014
Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical ResearchTove Tuntland, Brian Ethell, Takatoshi Kosaka, et al.
Pulmonary Pharmacology & Therapeutics|April 15, 2022
Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021) 102068]Roland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
Pulmonary Pharmacology & Therapeutics|July 30, 2021
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthmaRoland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolically Stable tert-Butyl ReplacementDavid Barnes-Seeman, Monish Jain, Leslie Bell, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|December 4, 2003
1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activationMonish Jain, Chul-Hoon Kwon
Biomedical Chromatography : BMC|April 10, 2024
Highly sensitive liquid chromatography-mass spectrometry method for the quantitative analysis of mometasone furoate in human plasma: Method validation and application to clinical pharmacokinetic studiesOlivier Heudi, Monish Jain, Serge Winter
Journal of Medicinal Chemistry|July 9, 2004
Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell linesMonish Jain, Junying Fan, Nesrine Z Baturay, et al.
Translational Vision Science & Technology|November 17, 2022
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy ParticipantsKalliopi Stasi, Qusai Alshare, Monish Jain, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 23, 2021
Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler<sup>®</sup> Device in Patients with AsthmaChristian Bartels, Monish Jain, Jing Yu, et al.
Drug Research|March 8, 2021
Xinting Wang, Christian Bartels, Swarupa Kulkarni, et al.
Frontiers in Pharmacology|August 15, 2014
Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical ResearchTove Tuntland, Brian Ethell, Takatoshi Kosaka, et al.
Pulmonary Pharmacology & Therapeutics|April 15, 2022
Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021) 102068]Roland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
Pulmonary Pharmacology & Therapeutics|July 30, 2021
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthmaRoland Buhl, Ivan Nikolaev, Hanns-Christian Tillmann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolically Stable tert-Butyl ReplacementDavid Barnes-Seeman, Monish Jain, Leslie Bell, et al.
Pageof 3